Endometriosis: who works on it

One card per institution. Pick a target or a country to narrow the list.

• All targets
• VEGF 0
• CTNNB1 0
• PPAR 0
• PI3K 0
• TP53 0
• AKT 0
• NLRP3 0
• TNF 0
• IL-6 0
• MMP-9 0
• NRF2 0
• AMPK 0
• ERK 0
• HIF-1 0
• JAK 0
• mTOR 0
• PTEN 0
• SIRT1 0
• TLR4 0
• HSP90 0
• MAPK 0
• STAT3 0
• BRCA1 0
• COX-2 0
• CXCR4 0
• EGFR 0
• ESR1 0
• HMGB1 0
• IL-1 0
• PD-1 0
• PKM2 0
• STING 0
• YAP 0
• BAP1 0
• BCL-2 0
• BDNF 0
• BRCA2 0
• CCR5 0
• CGRP 1
• CSF1R 0
• FAK 0
• FGFR 0
• FOXP3 0
• G6PD 0
• GPX4 0
• JNK 0
• KRAS 1
• LAG-3 0
• MDM2 0
• MYC 0
• PARP 0
• PD-L1 0
• PDGFR 0
• PRMT5 0
• SGLT2 0
• TIGIT 0
• TREM2 0
• VHL 0

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-GF

  Tracking the Intestinal Permeation and Circulation Effects of Environmental MicroPlastics (TRACE-MP)

  Queen Mary University of London· London, United Kingdom· EU contribution €292,073· until Jan 2029· 2 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC-POC

  Uro-Lieve: Slow-Release Capsaicin Hydrogel for Disease-Modifying Therapy of Painful Bladder Syndrome

  University of Galway· Galway, Ireland· EU contribution €150,000· until Nov 2027

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC-POC

  Simultaneous Yield of Non-invasive uterine Contractions via Wearable Observation and Real-time Monitoring A wearable platform for dynamic uterine motion capture. (SyncWorm)

  Gottfried Wilhelm Leibniz Universitaet Hannover· Hannover, Germany· EU contribution €150,000· until Nov 2027

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-SE

  Untapping the potential for improved female reproductive healthcare: diagnosing and reinforcing the status of UTERINE-associated fertility (TULIP)

  Karolinska Institutet· Stockholm, Sweden· EU contribution €1,803,600· until Dec 2029· 6 countries

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Investigating how somatic mutation induced changes in the eutopic endometrial microenvironment cause endometriosis (MERMAID)

  Stichting Radboud Universitair Medisch Centrum· Nijmegen, Netherlands· EU contribution €232,916· until Dec 2027

5 of 14 running projects, newest first. Listed amounts together: €27.6m.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Trials whose registry record says individual participant data (IPD) will be shared.

No trial in this view states that it shares participant data.

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 21
• Organoids 13
• Mendelian Randomization Analysis 29
• CRISPR-Cas Systems 1
• Gene Expression Profiling 44
• Sequence Analysis, RNA 6
• Exome Sequencing 2
• Proteomics 12
• Metabolomics 7
• Mass Spectrometry 2
• Flow Cytometry 7
• Immunohistochemistry 18
• Liquid Biopsy 1
• Xenograft Model Antitumor Assays 1
• Positron-Emission Tomography 3
• Magnetic Resonance Imaging 53
• Machine Learning 31
• Deep Learning 4
• Cohort Studies 48
• Genome-Wide Association Study 34

• Proteomic Profiling of Endometriosis and Ovarian Endometrioid Carcinoma: A Preliminary Exploratory Study.

  Technol Cancer Res Treat, Oct 2026

• Multi-omics profiling identifies an immunometabolic signature associated with endometriosis.

  Front Endocrinol (Lausanne), Aug 2026

• Translational Assessment of Omics Approaches in Endometriosis: Bridging Molecular Discovery with Clinical Utility.

  Int J Mol Sci, May 2026

• Proteomic Analysis of Cervicovaginal Fluid for Diagnostic Endometriosis Biomarker Discovery.

  Proteomics Clin Appl, May 2026

• Multi-ancestry genome-wide association and integrated multi-omics analyses of endometriosis and its clinical manifestations.

  Nat Genet, Apr 2026

• Plasma proteomic signature of the human menstrual cycle.

  Nat Med, Apr 2026

• Targeting HSP90 as a therapeutic approach for endometriosis: insights from proteomic analysis.

  Reproduction, Feb 2026

• Identification of candidate microRNA biomarkers of endometriosis in different bodily fluids.

  Sci Rep, Jan 2026

• Identifying Novel Biomarkers and Therapeutic Targets for Endometriosis: Integrative Analysis of the Plasma Proteome and Genome.

  Mediators Inflamm, Jan 2026

• Metabolome analysis as a potential source of endometriosis biomarkers with the use of multiomics approach in its diagnosis.

  Sci Rep, Nov 2025

See which targets of this disease your abstract mentions, and go to the people working on them.